SELLAS LIFE SCIENCES GROUP, INC.
Last · NASDAQ$11.88-0.53 (-4.27%)close · yahoo · 8h ago
Vol 4.70M ≈ 55.82M
MA10MA20MA50
Market cap$2.40B201.9M sh
P/E · TTM-56.6fwd -119 · eps -0.21 · loss
Beta2.57vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.39$15.88
Volume4.7Msession
Issuer
Legal nameSELLAS LIFE SCIENCES GROUP, INC.
HQUnited States (US)
ListingUS SLS
ISINUS81642T2096
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001390478
CIK0001390478
Websitewww.sellaslifesciences.com
Employees13
AddressSELLAS Life Sciences Group, Inc. Times Square Tower 10036, New York
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-19
From latest 10-K · 2026-03-19
- Operating Cf Burn
- Cash Runway Medium
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Medium — Cash runway ~2.5 years
- Accumulated Deficit High — Accumulated deficit / equity 388%
Upcoming earnings
WED.11NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.05
Est. revenue
0
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 134 filings